1	Cytomegalovirus	Cytomegalovirus	_	_	_	_	_	_	_
2	immediate	immediate	_	_	_	_	_	_	_
3	early	early	_	_	_	_	_	_	_
4	genes	gene	_	_	_	_	_	_	_
5	upregulate	upregulate	_	_	_	_	_	_	_
6	interleukin-6	interleukin-6	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	immediate	immediate	_	_	_	_	_	_	_
5	early	early	_	_	_	_	_	_	_
6	genes	gene	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	IE	IE	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	cytomegalovirus	cytomegalovirus	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	CMV	CMV	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	can	can	_	_	_	_	_	_	_
17	be	be	_	_	_	_	_	_	_
18	expressed	express	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	monocytic	monocytic	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	are	be	_	_	_	_	_	_	_
24	known	know	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	regulate	regulate	_	_	_	_	_	_	_
27	viral	viral	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	cellular	cellular	_	_	_	_	_	_	_
30	genes	gene	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Interleukin-6	Interleukin-6	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	IL-6	IL-6	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	plays	play	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	central	central	_	_	_	_	_	_	_
8	role	role	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	numerous	numerous	_	_	_	_	_	_	_
11	inflammatory	inflammatory	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	immune	immune	_	_	_	_	_	_	_
14	processes	process	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Interleukin-6	Interleukin-6	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	increased	increase	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	lung	lung	_	_	_	_	_	_	_
7	transplant	transplant	_	_	_	_	_	_	_
8	patients	patient	_	_	_	_	_	_	_
9	clinically	clinically	_	_	_	_	_	_	_
10	diagnosed	diagnose	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	CMV	CMV	_	_	_	_	_	_	_
13	pneumonitis	pneumonitis	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	IL-6	IL-6	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	dependent	dependent	_	_	_	_	_	_	_
7	on	on	_	_	_	_	_	_	_
8	various	various	_	_	_	_	_	_	_
9	stimuli	stimulus	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	include	include	_	_	_	_	_	_	_
12	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	LPS	LPS	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	viruses	virus	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	other	other	_	_	_	_	_	_	_
21	cytokines	cytokine	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	ability	ability	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	CMV	CMV	_	_	_	_	_	_	_
8	IE	IE	_	_	_	_	_	_	_
9	gene	gene	_	_	_	_	_	_	_
10	products	product	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	modulate	modulate	_	_	_	_	_	_	_
13	IL-6	IL-6	_	_	_	_	_	_	_
14	production	production	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	THP-1	thp-1	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	monocytic	monocytic	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	line	line	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	transfected	transfecte	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	CMV	CMV	_	_	_	_	_	_	_
16	IE	IE	_	_	_	_	_	_	_
17	genes	gene	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Interleukin-6	Interleukin-6	_	_	_	_	_	_	_
2	protein	protein	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	IL-6	IL-6	_	_	_	_	_	_	_
5	mRNA	mRNA	_	_	_	_	_	_	_
6	were	be	_	_	_	_	_	_	_
7	measured	measure	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	control	control	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	CMV	CMV	_	_	_	_	_	_	_
12	immediate	immediate	_	_	_	_	_	_	_
13	early	early	_	_	_	_	_	_	_
14	transfected	transfecte	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Cotransfection	Cotransfection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	CMV	CMV	_	_	_	_	_	_	_
4	IE	IE	_	_	_	_	_	_	_
5	genes	gene	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	IL-6	il-6	_	_	_	_	_	_	_
8	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
9	acetyl	acetyl	_	_	_	_	_	_	_
10	transferase	transferase	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	CAT	CAT	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	IL-6	IL-6	_	_	_	_	_	_	_
16	luciferase	luciferase	_	_	_	_	_	_	_
17	constructs	construct	_	_	_	_	_	_	_
18	were	be	_	_	_	_	_	_	_
19	used	use	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	study	study	_	_	_	_	_	_	_
22	IL-6	il-6	_	_	_	_	_	_	_
23	promoter	promoter	_	_	_	_	_	_	_
24	activity	activity	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Interleukin-6	interleukin-6	_	_	_	_	_	_	_
4	protein	protein	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	mRNA	mrna	_	_	_	_	_	_	_
7	production	production	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	significantly	significantly	_	_	_	_	_	_	_
10	increased	increase	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	transfected	transfecte	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	CMV	CMV	_	_	_	_	_	_	_
17	IE	IE	_	_	_	_	_	_	_
18	genes	gene	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	stimulated	stimulate	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	LPS	lps	_	_	_	_	_	_	_
23	compared	compare	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	LPS-stimulated	lps-stimulated	_	_	_	_	_	_	_
26	control	control	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Cytomegalovirus	Cytomegalovirus	_	_	_	_	_	_	_
2	IE	IE	_	_	_	_	_	_	_
3	gene	gene	_	_	_	_	_	_	_
4	products	product	_	_	_	_	_	_	_
5	significantly	significantly	_	_	_	_	_	_	_
6	enhanced	enhance	_	_	_	_	_	_	_
7	LPS	LPS	_	_	_	_	_	_	_
8	stimulation	stimulation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	IL-6	IL-6	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	IL-6	IL-6	_	_	_	_	_	_	_
16	CAT	CAT	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	IL-6	IL-6	_	_	_	_	_	_	_
19	luciferase	luciferase	_	_	_	_	_	_	_
20	assays	assay	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	deletion	deletion	_	_	_	_	_	_	_
3	construct	construct	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	contains	contain	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	site	site	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	missing	miss	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	multiple	multiple	_	_	_	_	_	_	_
15	response	response	_	_	_	_	_	_	_
16	region	region	_	_	_	_	_	_	_
17	demonstrated	demonstrate	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	continued	continued	_	_	_	_	_	_	_
20	increase	increase	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	IL-6	IL-6	_	_	_	_	_	_	_
23	luciferase	luciferase	_	_	_	_	_	_	_
24	activity	activity	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	LPS-stimulated	lps-stimulated	_	_	_	_	_	_	_
27	CMV	CMV	_	_	_	_	_	_	_
28	transfected	transfected	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	CONCLUSION	conclusion	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Cytomegalovirus	Cytomegalovirus	_	_	_	_	_	_	_
4	immediate	immediate	_	_	_	_	_	_	_
5	early	early	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	products	product	_	_	_	_	_	_	_
8	significantly	significantly	_	_	_	_	_	_	_
9	enhanced	enhance	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	IL-6	il-6	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	LPS-stimulated	lps-stimulated	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	increase	increase	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	IL-6	IL-6	_	_	_	_	_	_	_
5	luciferase	luciferase	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	occurs	occur	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	absence	absence	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	multiple	multiple	_	_	_	_	_	_	_
14	response	response	_	_	_	_	_	_	_
15	region	region	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	area	area	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	IL-6	il-6	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	responsive	responsive	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	IL-1	il-1	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	TNF	TNF	_	_	_	_	_	_	_
28	alpha	alpha	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	cyclic	cyclic	_	_	_	_	_	_	_
31	amp	amp	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	phorbol	phorbol	_	_	_	_	_	_	_
35	12-myristate	12-myristate	_	_	_	_	_	_	_
36	13-acetate	13-acetate	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	ability	ability	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	CMV	CMV	_	_	_	_	_	_	_
5	IE	IE	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	products	product	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	enhance	enhance	_	_	_	_	_	_	_
10	IL-6	il-6	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	may	may	_	_	_	_	_	_	_
13	play	play	_	_	_	_	_	_	_
14	an	an	_	_	_	_	_	_	_
15	important	important	_	_	_	_	_	_	_
16	role	role	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	immune	immune	_	_	_	_	_	_	_
19	inflammatory	inflammatory	_	_	_	_	_	_	_
20	states	state	_	_	_	_	_	_	_
21	associated	associate	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	CMV	CMV	_	_	_	_	_	_	_
24	infection	infection	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

